Incremento de las citoquinas proteína quimiotáctica de monocitos-1 (MCP-1) y proteína inflamatoria macrofágica-1β (MIP-1β) en líquido cefalorraquídeo de pacientes con esclerosis lateral amiotrófica
Open Access
- 1 April 2020
- journal article
- research article
- Published by Elsevier BV in Neurología
- Vol. 35 (3), 165-169
- https://doi.org/10.1016/j.nrl.2017.07.020
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- Deciphering amyotrophic lateral sclerosis: What phenotype, neuropathology and genetics are telling us about pathogenesisAmyotrophic Lateral Sclerosis and Frontotemporal Degeneration, 2013
- Blood–spinal cord barrier breakdown and pericyte reductions in amyotrophic lateral sclerosisActa Neuropathologica, 2012
- Neuroinflammation modulates distinct regional and temporal clinical responses in ALS miceBrain, Behavior, and Immunity, 2011
- CNS Infiltration of Peripheral Immune Cells: D-Day for Neurodegenerative Disease?Journal of Neuroimmune Pharmacology, 2009
- Increased levels of inflammatory chemokines in amyotrophic lateral sclerosisEuropean Journal of Neurology, 2009
- The size distribution of neurons in the motor cortex in amyotrophic lateral sclerosisJournal of Anatomy, 2005
- Macrophage inflammatory protein-1The International Journal of Biochemistry & Cell Biology, 2004
- Intrathecal synthesis of monocyte chemoattractant protein-1 (MCP-1) in amyotrophic lateral sclerosis: further evidence for microglial activation in neurodegenerationJournal of Neuroimmunology, 2003
- The natural history of central motor abnormalities in amyotrophic lateral sclerosisBrain, 2003
- Chemokine receptors: multifaceted therapeutic targetsNature Reviews Immunology, 2002